Bovine parainfluenza virus type 3 (bPIV-3) is a member of *Respirovirus* genus of the family *Paramyxoviridae*, genetically and antigenically related to human parainfluenza virus type 3 ([@b9]). In cattle, bPIV-3 is associated to the clinical condition known as "Shipping fever", a disease characterized by fever, apathy, anorexia, sneezing, serous and mucous nasal discharges, usually related to stress induced by transportation of cattle ([@b3], [@b19]). Occasionally, it has also been associated to abortions ([@b11], [@b19]). The virus is spread worldwide ([@b8], [@b10], [@b3]); in Brazil, bPIV-3 is endemically present - though seldom isolated - mainly linked to respiratory disorders ([@b4], [@b5], [@b3]).

Bovine viral diarrhea virus (BVDV) is by far the most common and widely recognized virus contaminating cell cultures ([@b1]); however, other viruses may be present. Viral contaminants can interfere with diagnosis of viral infections, since its unnoticed presence can lead to interference with the growth of other viruses. Vaccine produced on contaminated cells may in turn be contaminated, leading to immunossupression, seroconversion or disease in the vaccinated animals. Other parainfluenza viruses were found as contaminants in cell culture ([@b6]). On the present study, bPI3V contamination of bovine and swine cells is reported, and the cell isolates were phylogenetically compared to field strains.

In view of the limited number of available isolates, to date no molecular studies on Brazilian bPIV-3 were conducted. In the present study, the HN and L genes of two Brazilian bPIV-3 clinical isolates and another two bPI3V cell contaminants were partially sequenced and submitted to phylogenetic analyses.

Madin-Darby Bovine Kidney cells (MDBK, originally from ATCC, CCL-22) were used for virus production and assays. Cells were cultured according to usual methods ([@b7]). The bPVI-3 reference strain SF-4 (National Veterinary Laboratories Service, USA) was used as a positive control for RT-PCR tests. The bPVI-3 isolate DIO was recovered from nasal secretions of a calf with respiratory disease in Rio Grande do Sul, Brazil ([@b7]). Two other isolates were included, one from a case of bovine abortion occurred in the state of Goiás, Brazil (PG1775) and another recovered from an accidentally contaminated culture of MDBK cells (bPI3V/BR/cells). Another batch of Porcine kidney cells lineage (PK-15) showed also to be contaminated with this adventitious bPI3V isolate, and the virus was further isolated in non-contaminated MDBK cells. Strict biosafety measures were taken on the laboratory to avoid cross contamination.

All bPIV-3 isolates were cultured in virus-free MDBK cells following standard protocols ([@b7]). Viral RNA was extracted from viral stocks with Trizol (Invitrogen, Carlsbad, CA, USA) and chloroform, followed by sequential precipitations in 40% isopropanol and 70% ethanol ([@b15]).

Primers used were targeted to amplify bPIV-3 genomic fragments as proposed by ([@b16]). For cDNA synthesis, viral RNA (1 μg) was reverse transcribed with 200 units of M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and 200 ng of sense degenerate primers. Polymerase chain reactions (PCR) and sequencing were performed as described elsewhere ([@b18]). The SF-4/32 viral strain cultured in non-contaminated MDBK cells was used as positive control and deionized water as negative control. Similarly, another PCR was conducted to amplify and sequence the L polymerase gene from the cell culture contaminants, bPI3V/cells/MDBK and bPI3V/cells/PK-15, to better infer whether they are genetically related. After purification and quantification, the PCR products were submitted to nucleotide sequence analysis. Sequencing was carried with the *Big Dye Terminator Cycle Sequencing Ready Reaction* (Applied Biosystems, UK) in an ABI-PRISM 3100 Genetic Analyzer (ABI, Foster City, CA), according to the manufacturer\'s protocol. Three repetitions were performed on each amplified genomic fragment.

The sequence of SF4/32 strain (accession number AF178655) and other PIV-3 sequences available at GenBank database (accession numbers EU277658, NC002161, AF178654, U31671, E01754, Y00114, E01755, AB18996, AB189960, AY283065, Z26523, L25350, X55803, X56131 and X02808) were used for comparison for HN region; sequences AF178654, AF178655, D84095, EU277658, EU439429, and EU326526 were used for the L gene. The BioEdit software, version 7.01 (Hall 1999) was used to manipulate the nucleotide and amino acid of retrieved bPIV-3 sequences. The alignment of sequences was performed using the ClustalW software, version 2.0 ([@b13]).

Phylogenetic reconstructions based on the alignment of the HN and L genes nucleotide sequences are shown on [Figure 1](#fig1){ref-type="fig"}. Both trees ([Figure 1](#fig1){ref-type="fig"}, A and B) were calculated using the Maximum Parsimony method, in a bootstrap of 500 replicates. All calculations were made in MEGA5 ([@b17]). Homologous sequences from hPI3V were included as outgroups.

![Evolutionary relationship between bovine parainfluenza type 3 viruses (bPIV-3), as inferred from partial sequences of the gene HN (A) and L (B). The neighbor-joining method was used; only bootstrap values higher than 50 are shown. Brazilian strains (black lozenges) clustered together with the prototype strain SF4/32. The two distinguishable subgenotypes among bPIV-3 genotype A isolates are shown. Human PIV-3 was used as an out-group.](bjm-42-1440-g001){#fig1}

All Brazilian cell contaminants and clinical isolates clearly clustered in the same group as the prototype vaccine strain SF4/32, within the recently proposed genotype A Since the 1980\'s, when vaccination to bPI3V was introduced in Brazil, there are both live and killed vaccines marketed based on SF4 strain. One may consider that the isolates presented here may be related to the circulation of vaccine the field, which may be a possibility; however, those samples were collected from non-vaccinated cattle or were found as cell contaminants. This, together with the nucleotide differences found from the original SF4/32 strain, are indicating that those are wild bPI3V isolates.

Although the results presented here might be considered as preliminary, since they are based only in a few sequences, it can be seen in [Figure 1](#fig1){ref-type="fig"} that genotype A may present two distinct sub-lineages, one related to the SF4/32 strain, another with the 910N isolate; nevertheless, this have to be confirmed with a greater number of isolates. Analyzing the data collected on the present study, for the HN genomic portion, when isolates belonging to the same sub-lineage were compared intra-genotypically, a variation within the range 0.3 to 2.4% was recorded (with the exception of the variant isolate PG1775, 10.6%). The overall level of inter-subgenotypical variation for the HN gene was higher (7.8--15%) ([Table1](#tbl1){ref-type="table"}); however, the differences ranges for particular isolates do not fully support these conclusions, thus requiring further efforts on the collection and characterization of new bPI3V isolates. For the L gene, the identity for the analyzed genomic fragment was above 97% for strains inside the genotype A, and 84--89% between genotype B strains and viruses from genotype A. It is also suggestive that the isolates which were noticed as adventitious contaminat were virtually the same virus, since the sequences were highly similar. Isolation of bPI3V as a contaminant in cell cultures may be another matter of concern for laboratories dealing with research and diagnosis of bovine viral respiratory infections, or vaccine production, since the cytopathic effect of the virus is sometimes very discrete.

###### 

Identity percentages among partial nucleotide sequences (nucleotide positions 305 to 660) of the hemagglutinin-neuraminidase (HN) gene from different bovine parainfluenza virus type 3 (bPI3V) isolates. Human PI3V was considered as an out-group.

                                    AF178655 (bPI3V)SF-4   DQ839608 (bPI3V/BR/DIO)   bPI3V/BR/PG1775   bPI3V/BR/cells   EU439429 (SwinePI3V)   U31671 (bPI3V)   AF178654 (bPI3V)Kansas/15626/84   E01755(bPI3V)910N   E01754 (bPI3V)BRIV3M   EU277658 (bPI3V/Q5592)   AB189961 (hPI3V)
  --------------------------------- ---------------------- ------------------------- ----------------- ---------------- ---------------------- ---------------- --------------------------------- ------------------- ---------------------- ------------------------ ------------------
  AF178655(bPI3V)SF-4               --                     99.4                      92.4              98.3             99.7                   92.4             97.4                              91.9                91.3                   81.3                     75.2
  DQ839608(bPI3V/BR/DIO)            99.4                   --                        93                98.3             99.7                   92.4             97.4                              91.9                91.3                   81.3                     75.2
  bPI3V/BR/PG1775                   92.4                   93                        --                92.2             92.7                   85.7             90.5                              85.7                85.2                   75.4                     69.3
  bPI3V/BR/cells                    98.3                   98.3                      92.2              --               98                     90.8             95.8                              90.2                89.6                   79.9                     73.8
  EU439429(SwinePI3V)               99.7                   99.7                      92.7              98               --                     92.7             97.7                              92.2                91.6                   81.6                     75.4
  U31671(bPI3V)                     92.4                   92.4                      85.7              90.8             92.7                   --               92.2                              99.1                98.8                   83.2                     75.7
  AF178654(bPI3V) Kansas/15626/84   97.4                   97.4                      90.5              95.8             97.7                   92.2             --                                91.6                91                     82.7                     76.3
  E01755(bPI3V)910N                 91.9                   91.9                      85.7              90.2             92.2                   99.1             91.6                              --                  99.1                   83.5                     75.2
  E01754(bPI3V)BRIV3M               91.3                   91.3                      85.2              89.6             91.6                   98.8             91                                99.1                --                     83.2                     74.9
  EU277658(bPI3V/Q5592)             81.3                   81.3                      75.4              79.9             81.6                   83.2             82.7                              83.5                83.2                   --                       74.9
  AB189961(hPI3V)                   75.2                   75.2                      69.3              73.8             75.4                   75.7             76.3                              75.2                74.9                   74.9                     --

These findings provide additional evidence for diversity among bPI3V genotype A isolates, in agreement with previous reports based on antigenic and phenotypic analyses with monoclonal antibodies (2, 12--14). The impacts of this genomic diversity on the clinical pictures and preventive measures, especially vaccination, remain to be determined in the future.
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